Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Sawai Group Holdings Co., Ltd. (4887:JPX), powered by AI.
Sawai Group Holdings Co., Ltd. is currently trading at ¥1,674. View real-time AI analysis on Alpha Lenz.
View the latest insider trading data for Sawai Group Holdings Co., Ltd. on Alpha Lenz.
Sawai Group Holdings Co., Ltd.'s P/E ratio is 9.0.
“Sawai Group Holdings Co., Ltd. trades at a P/E of 9.0 (undervalued) with solid ROE of 11.9%.”
Ask for details →Sawai Group Holdings Co., Ltd. is an influential player in the pharmaceutical industry focusing on the manufacture and distribution of generic pharmaceuticals. The company's primary objective is to provide affordable and accessible medication options to the global market, emphasizing high quality and safety standards. Sawai Group Holdings engages in the development, production, and marketing of generic drugs that cater to a wide range of therapeutic areas, impacting both local and international healthcare sectors. Headquartered in Japan, the firm plays a significant role in the healthcare industry by addressing the ever-growing demand for cost-effective medication alternatives. Through continuous research and innovation, Sawai Group Holdings is committed to expanding its product portfolio and enhancing its contribution to global health care solutions.
“Sawai Group Holdings Co., Ltd. trades at a P/E of 9.0 (undervalued) with solid ROE of 11.9%.”
Ask for details →Sawai Group Holdings Co., Ltd. (ticker: 4887) is a company listed on JPX in the Healthcare sector (Drug Manufacturers - Specialty & Generic). It has approximately 3,310 employees. Market cap is $207.5B.
The current price is 1,674 with a P/E ratio of 9.05x and P/B of 1.19x.
ROE is 11.87% and operating margin is 11.01%. Annual revenue is $189.0B.